We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking DHR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
DH
ConfluenceDHR

Three Data Signals Align on Danaher

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Apr 2026, 06:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Danaher Corporation (DHR) share price and short interest (% of free float), three months to April 23, 2026
ORTEX data as of 27 Apr 2026, 06:00

Why this matters — Three distinct ORTEX data points have converged on DHR over the past week. Short interest, cost to borrow, and options positioning all shifted simultaneously as the life sciences tools company headed into a rocky earnings report.

Converging signals

Short sellers added 8.1% to their positions over the past week. Shares shorted climbed to 7.41 million by April 23, bringing short interest to 1.05% of float. The increase followed a volatile month that saw short interest jump 18.6% overall after a sharp spike on April 9.

Cost to borrow spiked 61% week-over-week to 0.64% before retreating to 0.45%. The borrowing rate has whipsawed between 0.18% and 0.67% over the past month. Utilization jumped from 0.12% to 0.19% on April 23, the highest level in three weeks.

Options traders turned more bearish. The put-call ratio climbed to 0.99 on April 24, a 2.3 standard deviation move above its 20-day mean of 0.76. The ratio had hovered near 0.70 for most of March before rising sharply in mid-April.

Corroborating context

Nine analyst firms lowered price targets over the past two weeks. Morgan Stanley cut to $255 from $270 on April 23. Goldman Sachs dropped to $230 from $265. Wells Fargo reduced its target to $212 from $240. All maintained buy-equivalent ratings despite the cuts.

Insiders sold $3.99 million over the past 90 days with net selling of 18,266 shares. Most transactions were routine equity compensation sales by senior executives on February 24 and 27.

The company ranks in the 88th percentile on ORTEX short score. Momentum and EPS momentum scores sit at the 60th and 52nd percentiles respectively.

Data summary

  • Short interest: 1.05% of float (+8.1% over 1 week, +18.6% over 1 month)
  • Cost to borrow: 0.45% (±61% volatility week-over-week)
  • Utilization: 0.19% (up from 0.12% prior day)
  • Put-call ratio: 0.99 (Z-score +2.3)
  • Stock price: $177.25 (-9.0% over 1 week, -6.8% over 1 month)
  • Days to cover: 2.55
  • Analyst consensus: Buy (19 buy ratings, recent target cuts averaging -$25)
  • Insider net 90d: -$4.0M
  • Next earnings: May 5, 2026

This is not financial advice. ORTEX data may contain errors.

Against its own history

This week's change in short interest is 1.8 standard deviations above the company's typical weekly move over the past year.

Against its peers

Shares moved -9.0% over the past week against a median of -8.1% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open DHR on ORTEX →

How this article was generated

Generated
27 Apr 2026, 08:59
Data as of
27 Apr 2026, 06:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.